The FDA has cleared Acon Laboratories' over-the-counter at-home COVID-19 antigen test, the second test authorized through the traditional premarket review pathway. It is the first test approved for use in children under 18. The test was initially granted emergency-use authorization in 2021 to be available without a prescription. In a FDA-reviewed study, the test showed 89.8% accuracy in identifying positive samples and 99.3% accuracy in identifying negative samples in individuals with upper respiratory infection symptoms.
In un'altra lingua
dal contenuto originale
www.medscape.com
Approfondimenti chiave tratti da
by Clinical Rev... alle www.medscape.com 11-09-2023
http://www.medscape.com/viewarticle/998294Domande più approfondite